证券代码：605117 证券简称：德业股份 公告编号：2025-104 乐静娜女士符合《公司法》《公司章程》等法律、法规中关于董事任职资格 和条件的规定。本次调整董事会成员后，公司董事会中兼任高级管理人员职务的 董事以及由职工代表担任的董事，总计未超过公司董事总数的二分之一。 特此公告。 宁波德业科技股份有限公司 董事会 宁波德业科技股份有限公司 关于选举第三届董事会职工代表董事的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 根据《中华人民共和国公司法》（以下简称"《公司法》"）、《上市公司章程指 引》、《关于新<公司法>配套制度规则实施相关过渡期安排》等有关规定，宁波 德业科技股份有限公司（以下简称"公司"）分别于 2025 年 10 月 29 日召开了第 三届董事会第十八次会议、2025 年 11 月 14 日召开了 2025 年第二次临时股东大 会，审议通过了《关于取消监事会、变更注册资本并修订<公司章程>的议案》， 公司将不再设置监事会。公司于 2025 年 11 月 14 日召开了职工代表大会，同意 免 ...

证券代码：605117 证券简称：德业股份 公告编号：2025-103 宁波德业科技股份有限公司 2025年第二次临时股东会决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 本次会议是否有否决议案：无 一、 会议召开和出席情况 二、 议案审议情况 (一)非累积投票议案 (一)股东会召开的时间：2025 年 11 月 14 日 (二)股东会召开的地点：宁波市北仑区甬江南路 26 号研发楼 7 楼 (三)出席会议的普通股股东和恢复表决权的优先股股东及其持有股份情况： | 1、出席会议的股东和代理人人数 | 581 | | --- | --- | | 2、出席会议的股东所持有表决权的股份总数（股） | 621,671,037 | | 3、出席会议的股东所持有表决权股份数占公司有表决权股 | | | 份总数的比例（%） | 68.6278 | (四)表决方式是否符合《公司法》及《公司章程》的规定，股东会主持情况等。 本次股东会由公司董事会召集，公司董事长张和君先生主持，会议采取现场 投票和网络投票相结合的方式进 ...

北京大成（宁波）律师事务所 关 于 宁波德业科技股份有限公司 2025 年第二次临时股东大会的 法 律 意 见 书 www.dentons.cn 浙江省宁波市和济街 180 号国际金融中心 E 座 17-18 楼 315040 电话 +86 574 8732 6088 传真 +86 574 8789 3911 二〇二五年十一月 宁波德业科技股份有限公司2025年第二次临时股东大会 北京大成（宁波）律师事务所 关于宁波德业科技股份有限公司 2025 年第二次临时股东大会的法律意见书 致：宁波德业科技股份有限公司 根据《中华人民共和国证券法》（以下简称"《证券法》"）、《中华人民共和 国公司法》（以下简称"《公司法》"）和中国证券监督管理委员会《上市公司股 东会规则》（以下简称"《股东会规则》"）等法律、法规和其他有关规范性文件 的要求，北京大成（宁波）律师事务所（以下简称"本所"）接受宁波德业科技股 份有限公司（以下简称"公司"）的委托，指派律师参加公司 2025 年第二次临时 股东大会（以下简称"本次股东大会"）。 本所声明：本所律师仅对本次股东大会的召集程序、召开程序、出席会议人 员资格、召集人资格、表决程 ...

Group 1 - The company announced plans to issue overseas shares (H-shares) and list on the Hong Kong Stock Exchange to enhance its global development strategy and brand influence [1][3] - The company is in discussions with intermediaries regarding the specifics of the H-share listing, with no changes expected in the controlling shareholder or actual controller [3] - The company reported a revenue of 8.846 billion yuan, a year-on-year increase of 10.36%, and a net profit of 2.347 billion yuan, a year-on-year increase of 4.79% for the first three quarters of 2025 [3] Group 2 - The company disclosed changes in the use of raised funds, terminating the "annual production of 25.5GW string and storage inverter production line" project and introducing a new "annual production of 7GWh industrial storage production line" project [4] - Approximately 651 million yuan of unused raised funds will be redirected to the new project, with any funding shortfall to be addressed through self-funding or other means [4] - The changes in fundraising projects do not constitute related party transactions or significant asset restructuring as defined by regulations [4]

Core Viewpoint - The lithium battery materials sector is experiencing a comprehensive price increase, which is expected to significantly enhance the profitability of related companies [2] Group 1: Lithium Battery Materials Price Increases - As of November 13, the average price of lithium hexafluorophosphate is 131,000 yuan/ton, up approximately 110% from early October, with a peak price exceeding 142,000 yuan/ton [2] - The average price of electrolyte is 25,700 yuan/ton, having increased by 7,000 yuan/ton (40%) since early October, with a maximum price of 29,000 yuan/ton [2] - The average price of VC additive is 87,500 yuan/ton, reflecting a cumulative increase of 41,000 yuan/ton (about 90%) since early October [2] - The average price of lithium iron phosphate is 36,900 yuan/ton, up 3,300 yuan/ton (about 10%) since early October [2] - The average price of wet-process separators is 0.78 yuan/sq.m, having risen by 0.03 yuan/sq.m (about 5%) since early October [2] Group 2: Energy Storage System Demand - The cumulative bidding scale for domestic energy storage systems reached 166.3 GWh from January to October, representing a year-on-year increase of approximately 172% [3] - The average price of 4-hour energy storage systems is 0.52 yuan/Wh, which has increased by 0.06 yuan/Wh month-on-month [3] - New energy storage installations totaled 85.5 GWh from January to October, showing a year-on-year growth of 71% [3] - The total scale of newly registered energy storage projects in October exceeded 128.9 GWh, marking a year-on-year increase of 224% [3] Group 3: AI Data Center Capital Expenditure - Major internet companies are increasing capital expenditures to meet the explosive demand from AI and cloud computing, with Google raising its 2025 capital expenditure guidance to between 91 billion and 93 billion USD, and Meta increasing it to between 70 billion and 72 billion USD [4] - OpenAI plans to launch the "Stargate" data center in 2026, with a planned capacity exceeding 8 GW and an expected investment of over 450 billion USD in the next three years [4] Group 4: Smart Meter Price Recovery - The third round of bidding for smart meters by the State Grid has seen a significant price rebound due to new specifications and changes in pricing standards [5] - The recovery in smart meter prices is expected to improve the profitability and performance elasticity of related companies in the meter industry [5] Group 5: Investment Recommendations - Companies to focus on include leading firms in the lithium battery industry such as CATL, Yiwei Lithium Energy, and others [2] - In the energy storage sector, key companies include Sungrow Power Supply, Yiwei Lithium Energy, and others [3] - For AI data center-related investments, companies like Jinpan Technology and others are recommended [4] - In the smart meter sector, companies such as Haixing Electric and others are highlighted [5]

Group 1: Company Performance - SMIC reported a revenue of 17.162 billion yuan in Q3 2025, a year-on-year increase of 9.9%, with a net profit of 1.51 billion yuan, up 43.1% year-on-year. For the first three quarters, revenue reached 49.51 billion yuan, growing 18.2%, and net profit was 3.81 billion yuan, an increase of 41.1% year-on-year [1] - BoRui Pharma's BGM1812 injection has received clinical trial approval for weight loss indications, with no similar targeted formulations approved globally [2] - Li Zhong Group's subsidiaries received project confirmations for aluminum alloy wheels from major international automotive manufacturers, with expected total sales of approximately 1.135 billion yuan [4] Group 2: Corporate Actions - Kanda New Materials announced the termination of the acquisition of equity in North One Semiconductor due to unmet progress expectations and lack of consensus among parties [3] - Lide Man plans to acquire 70% of Xiansheng Xiangrui for 1.733 billion yuan, aiming to enter the bioproducts industry [9] - Arctech's controlling shareholder CSIQ expects total revenue of 1.3 to 1.5 billion USD in Q4 2025, with a gross margin of 14% to 16% [6] Group 3: Market Activity - Taihe Technology's VC project phase two construction will be adjusted based on phase one market expansion, indicating some uncertainty [5] - Hezhong China has experienced significant stock price fluctuations, with a cumulative increase of 230.84% over 12 out of 13 trading days, leading to potential application for trading suspension if abnormal price increases continue [7][8]

Company Announcements - 合富中国's stock price has significantly deviated from its fundamentals, with a cumulative increase of 230.84% over the past 13 trading days, leading to potential suspension for further investigation if abnormal price increases continue [1] - 摩尔线程 plans to conduct its initial public offering with a total of 70 million shares, representing 14.89% of the post-issue total share capital, with the initial inquiry date set for November 19 and subscription date for November 24 [2] - *ST东易's stock has risen by 241.59% since September 26, prompting a suspension for investigation starting November 14 [2] - 华蓝集团 is planning a change in company control, leading to a suspension of its stock from November 14 for up to 2 trading days [4] - 吉电股份 intends to invest 5.698 billion yuan in a coal power project with a total investment of 56.98 billion yuan, which is part of a national energy strategy [6] - 利德曼 plans to acquire 70% of 先声祥瑞 for 1.733 billion yuan, aiming to enter the bioproducts industry [6] - 佛塑科技 is collaborating with 紫金矿业 to establish a project company for a lithium sulfide pilot project with a total investment of 1.13 billion yuan [7] - 中芯国际 reported a 43% year-on-year increase in net profit for Q3, driven by increased wafer sales [8] Financing and Investments - 云南铜业 plans to increase its investment in 中铜国贸 by 640 million yuan to enhance its capital strength [11] - 德业股份 is preparing to issue H-shares and list on the Hong Kong Stock Exchange to expand its global presence [20] Shareholder Changes - 闽发铝业's second-largest shareholder, 黄天火, has reduced his stake by 938.15 million shares, representing 0.9995% of the total share capital [3] - 长联科技's shareholders plan to collectively reduce their holdings by up to 4.37% [14] Project Awards - 和顺电气 has been awarded a storage power supply service project by 中国石油集团, with a bid amount of approximately 40.003 million yuan [18] - 安徽建工's subsidiary has won two EPC projects with a total bid amount of 1.753 billion yuan [19]

北京商报讯(记者马换换王蔓蕾)11月13日晚间，德业股份（605117）披露公告称，公司正在筹划发行境 外股份(H股)并在香港联交所上市事宜。 德业股份表示，为进一步推进公司全球化发展战略，提升公司品牌国际影响力与核心竞争力，积极借助 国际资本市场拓宽多元融资渠道，以全面提升公司治理水平，公司正在筹划发行境外股份(H股)并在香 港联交所上市事宜。公司正与相关中介机构就本次H股上市的具体推进工作进行商讨，相关细节尚未确 定，本次H股上市不会导致公司控股股东和实际控制人发生变化。 交易行情显示，截至11月13日收盘，德业股份股价收涨3.58%，收于83.85元/股，总市值761.2亿元。 ...

Group 1 - China Pacific Insurance's subsidiary, China Pacific Life, reported a cumulative premium income of 241.32 billion yuan for the first ten months, a year-on-year increase of 9.9% [1] - China Pacific Property Insurance, another subsidiary, achieved a cumulative premium income of 173.57 billion yuan, with a year-on-year growth of 0.4% [1] - Nocera Biopharma reported a net loss of 64.41 million yuan for the first three quarters, despite a revenue increase of 59.85% to 1.115 billion yuan [1] Group 2 - Founder Securities received approval from the China Securities Regulatory Commission to issue short-term corporate bonds not exceeding 5 billion yuan [1] - Haicheng Bonda's director plans to reduce his stake by up to 0.97%, equating to 198,400 shares [1] - Yuyuan Group intends to repurchase shares worth between 200 million and 300 million yuan, with a maximum price of 8.60 yuan per share [1] Group 3 - Huaren Shuanghe's subsidiary passed the GMP compliance inspection for a specific diabetes medication [4] - Lichong Group received project notifications from three international automotive manufacturers, with expected sales amounting to approximately 1.135 billion yuan [6] - Deyang Co. is planning to issue H-shares and list on the Hong Kong Stock Exchange to enhance its global strategy [7] Group 4 - Longxin General announced the transfer of its entire stake in a subsidiary for 105.6 million yuan, and also plans to divest another stake for 1 yuan due to poor performance [16] - Kangda New Materials decided to terminate the acquisition of a semiconductor company due to unsatisfactory due diligence progress [17] - Lu'an Environmental reported a 3.28% year-on-year increase in coal sales for October, totaling 3.78 million tons [18] Group 5 - Shanghai Port Group plans to invest 2 billion yuan to establish a new holding company with several state-owned enterprises [20] - Borui Pharmaceutical's new drug for obesity treatment has received clinical trial approval [23] - Silver Dragon Co. has completed the registration of a new energy industry fund focusing on high-growth potential projects [24] Group 6 - Hengrui Medicine received approval for a clinical trial of a prostate cancer drug [11] - Baiji Shenzhou reported a net profit of 1.139 billion yuan for the first three quarters, marking a turnaround from losses [36] - Huasheng Pharmaceutical's special medical food product has received registration certification [60]

Core Viewpoint - Ningbo Deye Technology Co., Ltd. is planning to issue overseas shares (H-shares) and list on the Hong Kong Stock Exchange to enhance its global development strategy and brand influence [1] Group 1: Company Strategy - The company aims to improve its international competitiveness and governance standards by leveraging international capital markets [1] - Discussions are ongoing with relevant intermediaries regarding the specifics of the H-share listing [1] Group 2: Regulatory Process - The H-share issuance will not change the controlling shareholder or actual controller of the company [1] - The plan requires approval from the company's board and shareholders, as well as registration with the China Securities Regulatory Commission and review by the Hong Kong Stock Exchange, indicating significant uncertainty in the implementation process [1] Group 3: Investor Communication - The company commits to timely information disclosure based on subsequent developments [1]